Literature DB >> 21923626

Determination of risk factors for isoniazid monoresistance and multidrug-resistant tuberculosis in treatment failure patients.

Viral Vadwai1, Anjali Shetty, Rajeev Soman, Camilla Rodrigues.   

Abstract

India has a high number of drug-resistant tuberculosis cases. Patient records were screened to determine risk factors possibly associated with monoresistance and multidrug-resistant tuberculosis (MDR-TB) in comparison with patients with susceptible TB. We retrospectively screened and selected 250 patient records from a tertiary care centre, in which detailed clinical histories were provided. Of the 250 patients, 10 had isoniazid monoresistant TB, 184 patients had MDR-TB, and 56 patients had TB susceptible to first-line drugs. Binary regression analysis revealed that previous treatment with a fluoroquinolone and an injectable other than streptomycin (odds ratio (OR) 3.889, 95% confidence interval (CI) 1.828-8.272) was associated with MDR-TB. Previous history of TB (OR 0.697, 95% CI 0.363-1.338) and the presence of cavities on radiographs (OR 0.371, 95% CI 0.160-0.862) did not show any association. None of these reported risk factors were associated with isoniazid monoresistance. In conclusion, a history of previous treatment with a fluoroquinolone and an injectable other than streptomycin was found to be a risk factor for MDR-TB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21923626     DOI: 10.3109/00365548.2011.611169

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

1.  Isoniazid Monoresistance and Rate of Culture Conversion among Patients in the State of Georgia with Confirmed Tuberculosis, 2009-2014.

Authors:  Argita D Salindri; Rose-Marie F Sales; Lauren DiMiceli; Marcos C Schechter; Russell R Kempker; Matthew J Magee
Journal:  Ann Am Thorac Soc       Date:  2018-03

2.  Are we doing enough to stem the tide of acquired MDR-TB in countries with high TB burden? Results of a mixed method study in Chongqing, China.

Authors:  Ying Li; John Ehiri; Eyal Oren; Daiyu Hu; Xingneng Luo; Ying Liu; Daikun Li; Qingya Wang
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

3.  Comparing risk factors for primary multidrug-resistant tuberculosis and primary drug-susceptible tuberculosis in Jiangsu province, China: a matched-pairs case-control study.

Authors:  Xin-Xu Li; Wei Lu; Rong-Qiang Zu; Li-Mei Zhu; Hai-Tao Yang; Cheng Chen; Tao Shen; Guang Zeng; Shi-Wen Jiang; Hui Zhang; Li-Xia Wang
Journal:  Am J Trop Med Hyg       Date:  2014-12-22       Impact factor: 2.345

4.  Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing.

Authors:  Evangelina Inácio Namburete; Inês Tivane; Miguelhete Lisboa; Margarida Passeri; Renata Pocente; Josefo Joao Ferro; Lee H Harrison; Valdes Roberto Bollela
Journal:  BMC Infect Dis       Date:  2016-08-17       Impact factor: 3.090

Review 5.  Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis.

Authors:  Vishal Goyal; Vijay Kadam; Prashant Narang; Vikram Singh
Journal:  BMC Public Health       Date:  2017-10-17       Impact factor: 3.295

6.  HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis.

Authors:  Zeeba Zahra Sultana; Farhana Ul Hoque; Joseph Beyene; Md Akhlak-Ul-Islam; Md Hasinur Rahman Khan; Shakil Ahmed; Delwer Hossain Hawlader; Ahmed Hossain
Journal:  BMC Infect Dis       Date:  2021-01-11       Impact factor: 3.090

7.  High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.

Authors:  Naima Fasih; Yasraba Rafiq; Kausar Jabeen; Rumina Hasan
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.